← Eichor
Study identifier: NCT06476184 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

Condition: Ovarian Cancer  ·  Sponsor: ARCAGY/ GINECO GROUP

PhasePhase 3
Planned participants250
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

SALVOVAR will be a pragmatic open-label multicenter randomized phase III trial (ratio 1:1) comparing the efficacy of the salvage weekly dose-dense regimen with those of the continuation of the standard regimen.

This description comes directly from the study's public registry record.

Talk to the study team

Marine COGNAT  ·  +33 1 84 85 20 20  ·  salvovar.trial@arcagy.org

Always discuss trial participation with your own doctor first.

Locations (72)

ICO Paul PapinAngers, FranceRecruiting
CH d'AvignonAvignon, FranceRecruiting
Sainte-Catherine Institut du Cancer Avignon-ProvenceAvignon, FranceRecruiting
Hôpital de la Côte BasqueBayonne, FranceRecruiting
CHRU Besançon - Hôpital Jean MinjozBesançon, FranceRecruiting
Institut BergoniéBordeaux, FranceRecruiting
CHU de BREST - Hôpital Cavale BlancheBrest, FranceRecruiting
Centre François BaclesseCaen, FranceRecruiting
Centre d'Oncologie et de Radiothérapie 37 (ROC37)Chambray-lès-Tours, FranceRecruiting
Centre Hospitalier de CholetCholet, FranceRecruiting
Centre Jean PerrinClermont-Ferrand, FranceRecruiting
Centre Hospitalier Alpes LemanContamine-sur-Arve, FranceNot Yet Recruiting

+ 60 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06476184